Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722107 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
ElectronicAdd to Basket



Commercial Insight: Osteoporosis and HRT - Novel Osteoporosis Drugs Counter Generic Threat While HRT Players Regroup and Move Forward
Datamonitor, Oct 2004, Pages: 78

  Description  
  Table of Contents  
  Sample  
    
    
   
 Enquire before Buying  
 Send to a Friend  
Send to a Friend
To email a friend details of Commercial Insight: Osteoporosis and HRT - Novel Osteoporosis Drugs Counter Generic Threat While HRT Players Regroup and Move Forward complete the form below and click on "Send".

 * Required Information
Your Friend's Details
  Friend's Full Name *

Friend's Email Address *

 

A message for your Friend
 
Your Contact Details
  Your Name *

 
Email Address *

 
 



Customers who bought this item also bought

Commercial Insight: Osteoporosis and HRT - HRT is down for the count, but can osteoporosis players pick up the pieces?

Commercial Insight: Osteoporosis and HRT - HRT is down for the count, but can osteoporosis players pick up the pieces?

Osteoporosis - Novel Agents to Battle for Payer Acceptance

Pipeline Insight: Osteoporosis - Intermittent Dosing Drives Market Growth

Osteoporosis Therapeutics - Global Strategic Business Report

Osteoporosis Therapeutics - A Global Market Perspective

Osteoporosis Therapeutics - A Global Market Perspective

US Osteoporosis Market

Drugs of Tomorrow: Osteoporosis - Will Bone Building Drugs Revolutionize the Market?

Stakeholder Insight: Osteoporosis - Generic Alendronate Further Establishes Oral Bisphosphonates as Gold Standard

Osteoporosis - The Science Of Compliance

Therapeutic and Pharmaceutical Opportunities for Osteoporosis and Atherosclerosis
Top of page


   All rights reserved. © Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds